Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/27/2007US20070298115 Nanoparticulate fibrate formulations
12/27/2007US20070298112 salt of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester and phosphoric acid; pulmonary disorders
12/27/2007US20070298108 Pharmaceutical Formulation
12/27/2007US20070298107 Pharmaceutical Compositions of Mirtazapine
12/27/2007US20070298105 Methods of treating conditions by sustained release administration of benzimidazole derivatives
12/27/2007US20070298104 Cyanoisoquinoline compounds and methods of use thereof
12/27/2007US20070298103 Particulates
12/27/2007US20070298102 Extended Release Pharmaceutical Composition of Celecoxib
12/27/2007US20070298101 Controlled-Release Formulation Comprising Tamsulosin Hydrochloride
12/27/2007US20070298100 Compressed Pharmaceutical Compositions Comprising Peg and Electrolytes
12/27/2007US20070298099 Liquid and Semi-Solid Pharmaceutical Formulations for Oral Administration of a Substituted Amide
12/27/2007US20070298098 Controlled Release Compositions Comprising Levetiracetam
12/27/2007US20070298096 Analgesic/Antipyretic Compositions for Enhanced Absorption
12/27/2007US20070298094 Medicinal Composition, Preparation and Combined Preparation
12/27/2007US20070298092 Compositions for Delivery of Drug Combinations
12/27/2007US20070298090 Intraoral delivery of nicotine for smoking cessation
12/27/2007US20070298089 Drug for External Use and Adhesive Patch
12/27/2007US20070298088 Tooth Whitening products
12/27/2007US20070298084 Flat System for Using in the Oral Cavity
12/27/2007US20070298083 Concentrated omega-3 fatty acids and mixtures containing them
12/27/2007US20070298081 Alleviating acute alcohol intoxication/side effects of a hangover by administering, for example, 2,3-dimercapto-1-propanol; food additives/supplements; animal feed; oxidation resistance; immunostimulants; demetallization; shelf life cosmetology; dermatology; food additives/supplements; feeds; drugs
12/27/2007US20070298079 Food fortified with omega-3 fatty acids
12/27/2007US20070298078 Water Soluble Article for Imparting Dietary Fiber to Bottled Water
12/27/2007US20070298076 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/27/2007US20070298071 Bioactive scaffold for therapeutic and adhesion prevention applications
12/27/2007US20070298065 2-Cyclopentyl-4-(4-phenoxyphenyl)thiazole-5-carboxamide; amidation; oxidation; cyclization;
12/27/2007US20070298062 Resin Powder For Dermatologic Composition, Skin Cleansing Agent and Cosmetic Composition Using the Powder, and Preparation Processes of the Powder
12/27/2007US20070298058 Pharmaceutical compositions comprising ascomycin
12/27/2007US20070298056 Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
12/27/2007US20070298051 Adjuvants Of Immune Response
12/27/2007US20070298048 Non-viral gene delivery system
12/27/2007US20070298043 Novel Antibacterial Agents and Methods of Identifying and Utilizing Same
12/27/2007US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
12/27/2007US20070298032 Proteins Involved In Quorum Sensing
12/27/2007US20070298029 Treatment of Neurodegenerative Diseases by the Use of Degs Inhibitors
12/27/2007US20070298028 Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3)
12/27/2007US20070298027 Novel Target for Antiderpressant Therapy
12/27/2007US20070298026 Methods for Identifying Treatment and Inducing Infertility Using Smc1-Beta
12/27/2007US20070298021 Methods and Compositions for the Treatment or Prevention of Secondary Ischemic Injury
12/27/2007US20070298012 Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules
12/27/2007US20070298010 For reducing aggregation or immunogenicity of peptide or polypeptide including an alkylglycoside, especially dodecyl maltoside, tridecyl maltoside, sucrose monododecanoate, sucrose monotridecanoate, or sucrose monotetradecanoate; treatment of obesity
12/27/2007US20070298009 protect neural cells from degeneration and/or death in response to traumatic brain injury or autoimmune disorders of the brain, such as multiple sclerosis and in reducing seizures; hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease
12/27/2007US20070298008 Method of bowel cleansing
12/27/2007US20070298007 Slow release biocidal thermoplastic compositions and articles
12/27/2007US20070298006 Dendritic Polymers With Enhanced Amplification and Interior Functionality
12/27/2007US20070298005 Injectable composition for treatment of skin defects or deformations
12/27/2007US20070297999 Kit containing an acidic composition and a composition based on a hydroxyalkyl urea
12/27/2007US20070297994 Film sizes to cover teeth; containing peroxy compound
12/27/2007US20070297991 Neural conduit agent dissemination for smoking cessation and other applications
12/27/2007US20070297990 Self-preserving composition
12/27/2007US20070297989 Novel anti-inflammatory androstane derivatives
12/27/2007US20070297985 Method and composition for enhancing bone formation
12/27/2007US20070297981 Formulations and methods for treating dry eye
12/27/2007US20070297980 Geldanamycin and Derivatives Inhibit Cancer Invasion and Identify Novel Targets
12/27/2007DE4447972B4 Pharmaceutical preparations contg macrolide antibiotics - contain, as the carrier, a mixt of a hydrophilic phase, a lipophilic phase and a surfactant
12/27/2007DE4240430B4 Stabilisiertes pharmazeutisches Mittel, enthaltend einen HMG-CoA-Reduktase-Inhibitor Wirkstoff A stabilized pharmaceutical composition comprising an HMG-CoA reductase inhibitor active agent
12/27/2007DE202006020214U1 Mittel zur Beeinflussung der Nozizeption und deren Folgen Means for influencing the nociception and its consequences
12/27/2007DE102006029573A1 Neue Quinazoline als Kinase-Inhibitoren New quinazolines as kinase inhibitors
12/27/2007DE102006029448A1 Pharmazeutische Zusammensetzung mit einem extrazellulären Polyanion aus Arthrospira A pharmaceutical composition comprising an extracellular polyanion from Arthrospira
12/27/2007DE102006029447A1 Oxo-substituierte Imidazo[1,2b]pyridazine, deren Herstellung und Verwendung als Arzneimittel Oxo-substituted imidazo [1,2-b] pyridazines, their preparation and use as medicaments
12/27/2007DE102006029445A1 Neue 3-Cyano-chinoline als Kinase-Inhibitoren New 3-cyano-quinolines as kinase inhibitors
12/27/2007DE102006029233A1 Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika Formulations to improve the compatibility of non-steroidal anti-inflammatory drugs
12/27/2007DE102006029074A1 4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe 4-amino-3-arylamino-6-arylpyrazolo [3,4-d] pyrimidine derivatives, processes for their preparation and their use as antiviral agents
12/27/2007DE102006028983A1 Phosphorsäurediesteramide Phosphorsäurediesteramide
12/27/2007DE102006028862A1 3-Amino-imidazo[1,2-a]pyridinderivate 3-amino-imidazo [1,2-a] pyridine
12/27/2007DE102006028649A1 New 5-quinoline derivatives are topoisomerase inhibitors useful to treat bacterial infections
12/27/2007DE102006028284A1 Agent, useful for the prevention and treatment of hyperammonemia, comprises cobalamine, folic acid, vitamin B6, betaine, L-arginine, L-ornithine, L-citrulline, L-valine, L-threonine, L-leucine, L-isoleucine, carnitine and phosphocreatine
12/27/2007DE102006021872A1 4,5-Diphenyl-pyrimidinyl-oxy oder -mercapto substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 4,5-diphenyl-pyrimidinyl-oxy or substituted mercapto carboxylic acids, process for their preparation and their use as medicaments
12/27/2007DE102006020327A1 Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung Heterocyclic-substituted, fused pyrazole derivatives and their use
12/27/2007CA2826738A1 Polynucleotides and polypeptide sequences involved in cancer
12/27/2007CA2691775A1 Metformin r-(+) lipoate as an antidiabetic agent for control of diabetic hyperglycemia and diabetic complications
12/27/2007CA2666688A1 Reduced coenzyme q10-containing composition and method for producing the same
12/27/2007CA2660650A1 Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
12/27/2007CA2660649A1 Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
12/27/2007CA2659582A1 Tyrosine kinase inhibitors
12/27/2007CA2658959A1 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
12/27/2007CA2657967A1 Cyclopentane derivatives as antiglaucoma agents
12/27/2007CA2657691A1 Methods and compositions for diagnostic and therapeutic targeting of cox-2
12/27/2007CA2657429A1 Ruminant feedstock dietary supplement
12/27/2007CA2657213A1 Peptide epoxyketones for proteasome inhibition
12/27/2007CA2656825A1 Method of treatment and agents useful for same
12/27/2007CA2656711A1 Novel hydrate form of moxifloxacin monohydrochloride
12/27/2007CA2656698A1 Cannabinoids for use in the treatment of neuropathic pain
12/27/2007CA2656643A1 Method for the treatment of neurological disorders by enhancing the activity of .beta.-glucocerebrosidase
12/27/2007CA2656625A1 Substituted isoindoles as bace inhibitors and their use
12/27/2007CA2656419A1 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/27/2007CA2656413A1 Oxo-substituted imidazo[1,2b]pyridazines, their preparation and use as pharmaceuticals
12/27/2007CA2656370A1 Quinazoline derivatives, their preparation, their use as tyrosine kinase inhibitors and medicaments comprising them
12/27/2007CA2656361A1 Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
12/27/2007CA2656339A1 Ship 1 modulator prodrugs
12/27/2007CA2656333A1 Ship 1 modulator compounds
12/27/2007CA2656264A1 Method for producing crystal polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid
12/27/2007CA2656064A1 Polymorphic forms and process
12/27/2007CA2656035A1 Crystalline duloxetine hydrochloride
12/27/2007CA2656034A1 Fused [d]pyridazin-7-ones
12/27/2007CA2656017A1 Use of pyridone derivatives in the prevention and treatment of radiation-induced lung injuries
12/27/2007CA2656002A1 Purinone derivatives as hm74a agonists
12/27/2007CA2656000A1 Pyrro[1,2-b]pyridazinone compounds
12/27/2007CA2655991A1 Crystalline duloxetine hydrochloride
12/27/2007CA2655986A1 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator
1 ... 3443 3444 3445 3446 3447 3448 3449 3450 3451 3452 3453 3454 3455 3456 3457 3458 3459 3460 3461 3462 3463 ... 7860